Although there are (besides our results) to the best of our knowledge no direct indications in the literature that SNPs in the P450 involved in the degradation of cholesterol are associated with PD, many indirect pieces of evidence exist, which underpin our conclusions. This evidence concerns the gene CYP2B6 and Parkinson disease.